Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the 13 Companies that Just Started Paying Dividends. During the Q4 2025 earnings call, CEO Leonard Schleifer reported 3% revenue growth, with double-digit growth in key products. Global net sales of DUPIXENT rose 32%, LIBTAYO sales increased 13%, and EYLEA HD sales in the U.S. were up 66%. Schleifer highlighted plans for FDA approvals and Phase III studies. Regeneron is a biotechnology company that develops medicines for serious diseases.

Read more at Yahoo Finance: Regeneron (REGN) Draws Higher Target From TD Cowen